Our Company

A patient walks out of her cataract surgery, accompanied by her nurse
  • Our Company

We are reimagining medicine

Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.

The Novartis  Vision

Our vision is to be a trusted leader in changing the practice of medicine.

Our Business

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.

Innovative Medicines

Made up of two business units – Novartis Pharmaceuticals and Novartis Oncology – our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

Learn More

Novartis Global Product Portfolio and Clinical Pipeline
Novartis Corporate History

Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.

Awards and Recognition

Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our corporate responsibility activities.

  • Woman scientist wearing protective clothes

    Fortune's Most Admired Pharmaceutical Companies 2019

    Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.